Transient inhibition of Th1-type cytokine production by CD4+ T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells

Immunology

Volumn 118, Issue 4, 2006, Pages 438-448

  Chichester, Jessica A ^a   Feitelson, Mark A ^a   Calkins, Catherine E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

CD4+ T cells; ELISPOT; IFN ; Regulatory T cells; Response kinetics

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 5; RECOMBINANT ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B CORE ANTIGENS; HEPATITIS B, CHRONIC; IMMUNIZATION; IMMUNOBLOTTING; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-5; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C3H; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 33746084822     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02397.x     Document Type: Article

References (47)

1. Czarniecki CW, Fennie CW, Powers DB, Estell DA. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol 1984; 49:490-6.
2. Wong GH, Goeddel DV. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 1986; 323:819-22.
3. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999; 162:1641-7.
4. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.
5. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825-9.
6. Milich DR, McLachlan A, Moriarty A, Thornton GB. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J Immunol 1987; 139:1223-31.
7. Milich DR, Chen MK, Hughes IL, Jones JE. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 1998; 160:2013-21.
8. Milich DR, Schodel F, Hughes JL, Jones JE, Peterson DL. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol 1997; 71:2192-201.
9. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:9-60.
10. Jung MC, Diepolder HM, Spengler U et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 1995; 69:3358-68.
11. Bertoletti A, D'Elios MM, Boni C et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112:193-9.
12. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993; 91:2586-95.
13. Ferrari C, Penna A, Sansoni P, Giuberti T, Neri TM, Chisari FV, Fiaccadori F. Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol 1986; 66:497-506.
14. Jung MC, Spengler U, Schraut W et al. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 1991; 13:310-17.
15. Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 1986; 234:1398-401.
16. Sallberg M, Norder H, Magnius LO. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B. J Med Virol 1990; 30:1-6.
17. Homann D, Teyton L, Oldstone MB. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 2001; 7:913-19.
18. Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 2003; 4:835-42.
19. Chichester JA, Feitelson MA, Calkins CE. Different response requirements for IFN-gamma production in ELISPOT assays by CD4+ T cells from mice early and late after immunization. J Immunol Methods 2006; 309:99-107.
20. Bennouna J, Hildesheim A, Chikamatsu K, Gooding W, Storkus WJ, Whiteside TL. Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses. J Immunol Meth 2002; 261:145-56.
21. Mannering SI, Cheers C. Interleukin-2 and loss of immunity in experimental Mycobacterium avium infection. Infect Immun 2002; 7:27-35.
22. Muralidhar G, Koch S, Haas M, Swain SL. CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med 1992; 175:1589-99.
23. Isogawa M, Furuichi Y, Chisari FV. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity 2005; 23:53-63.
24. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236:944-7.
25. Severinson E, Fernandez C, Stavnezer J. Induction of germ-line immunoglobulin heavy chain transcripts by mitogens and interleukins prior to switch recombination. Eur J Immunol 1990; 20: 1079-84.
26. Collins JT, Dunnick WA. Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma. Int Immunol 1993; 5:885-91.
27. Snapper CM, Finkelman FD, Paul WE. Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev 1988; 102:51-75.
28. McHeyzer-Williams MG. Combinations of interleukins 2, 4 and 5 regulate the secretion of murine immunoglobulin isotypes. Eur J Immunol 1989; 19:2025-30.
29. Freund J. The mode of action of immunologic adjuvants. Bibl Tuberc 1956; 10:130-48.
30. Herbert WJ. The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. Immunology 1968; 14:301-18.
31. McDevitt H. Specific antigen vaccination to treat autoimmune disease. Proc Natl Acad Sci USA 2004; 101 (Suppl. 2):14627-30.
32. Nelson D, Bundell C, Robinson B. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol 2000; 165:6123-32.
33. De Mattia F, Chomez S, Van Laethem F, Moulin V, Urbain J, Moser M, Leo O, Andris F. Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation. J Immunol 1999; 163:5929-36.
34. Jelley-Gibbs DM, Dibble IP, Filipson S, Haynes L, Kemp RA, Swain SL. Repeated stimulation of CD4 effector T cells can limit their protective function. J Exp Med 2005; 201:1101-12.
35. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-7.
36. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003; 198:889-901.
37. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004; 78:2454-9.
38. Dittmer U, He H, Messer RJ et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004; 20:293-303.
39. Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK, Bertoletti A. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005; 79:3322-8.
40. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41:771-8.
41. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2:301-6.
42. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003; 100:8886-91.
43. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004; 172:6519-23.
44. Bertoletti A, Chisari FV, Penna A et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 1993; 67:2376-80.
45. Ferrari C, Penna A, Bertoletti A et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145:3442-9.
46. Bocher WO, Dekel B, Schwerin W et al. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection. Eur J Immunol 2001; 31:2071-9.
47. Penna A, Del Prete G, Cavalli A et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25:1022-7.